Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randy D Blakely

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
Frontiers in Synaptic Neuroscience|January 22, 2016
Physical Interactions and Functional Relationships of Neuroligin 2 and Midbrain Serotonin TransportersRan Ye, Meagan A Quinlan, Hideki Iwamoto, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 4, 2021
Inflammation-Induced Histamine Impairs the Capacity of Escitalopram to Increase Hippocampal Extracellular SerotoninMelinda Hersey, Srimal Samaranayake, Shane N Berger, et al.
IEEE Journal of Translational Engineering in Health and Medicine|February 27, 2024
Optical Imaging Demonstrates Tissue-Specific Metabolic Perturbations in Mblac1 Knockout MiceBusenur Ceyhan, Parisa Nategh, Mehrnoosh Neghabi, et al.
Annals of the New York Academy of Sciences|November 20, 2002
Genetic basis of clinical catecholamine disordersEmily M Garland, Maureen K Hahn, Terry P Ketch, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2014
The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulantsMarc A Mergy, Raajaram Gowrishankar, Paul J Gresch, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 20, 2012
Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulationDhananjay Sakrikar, Michelle S Mazei-Robison, Marc A Mergy, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 27, 2017
The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent MechanismDaniel P Bermingham, J Andrew Hardaway, Osama Refai, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2016
Optimization of the choline transporter (CHT) inhibitor ML352: Development of VU6001221, an improved in vivo tool compoundJeanette L Bertron, Elizabeth A Ennis, Christopher J Tarr, et al.
Cell Reports|February 3, 2021
Gαo is a major determinant of cAMP signaling in the pathophysiology of movement disordersBrian S Muntean, Ikuo Masuho, Maria Dao, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 30, 2010
Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorderErica Bowton, Christine Saunders, Kevin Erreger, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
Frontiers in Synaptic Neuroscience|January 22, 2016
Physical Interactions and Functional Relationships of Neuroligin 2 and Midbrain Serotonin TransportersRan Ye, Meagan A Quinlan, Hideki Iwamoto, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 4, 2021
Inflammation-Induced Histamine Impairs the Capacity of Escitalopram to Increase Hippocampal Extracellular SerotoninMelinda Hersey, Srimal Samaranayake, Shane N Berger, et al.
IEEE Journal of Translational Engineering in Health and Medicine|February 27, 2024
Optical Imaging Demonstrates Tissue-Specific Metabolic Perturbations in Mblac1 Knockout MiceBusenur Ceyhan, Parisa Nategh, Mehrnoosh Neghabi, et al.
Annals of the New York Academy of Sciences|November 20, 2002
Genetic basis of clinical catecholamine disordersEmily M Garland, Maureen K Hahn, Terry P Ketch, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2014
The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulantsMarc A Mergy, Raajaram Gowrishankar, Paul J Gresch, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 20, 2012
Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulationDhananjay Sakrikar, Michelle S Mazei-Robison, Marc A Mergy, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 27, 2017
The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent MechanismDaniel P Bermingham, J Andrew Hardaway, Osama Refai, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2016
Optimization of the choline transporter (CHT) inhibitor ML352: Development of VU6001221, an improved in vivo tool compoundJeanette L Bertron, Elizabeth A Ennis, Christopher J Tarr, et al.
Cell Reports|February 3, 2021
Gαo is a major determinant of cAMP signaling in the pathophysiology of movement disordersBrian S Muntean, Ikuo Masuho, Maria Dao, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 30, 2010
Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorderErica Bowton, Christine Saunders, Kevin Erreger, et al.
Pageof 23